Copyright
©The Author(s) 2024.
World J Clin Cases. Jul 6, 2024; 12(19): 3918-3924
Published online Jul 6, 2024. doi: 10.12998/wjcc.v12.i19.3918
Published online Jul 6, 2024. doi: 10.12998/wjcc.v12.i19.3918
Parameter | Patient's value | Reference value |
Alanine aminotransferase | 71 U/L | 9-50 U/L |
Aspartate aminotransferase | 102 U/L | 15-40 U/L |
Alkaline phosphatase | 393 U/L | 45-125 U/L |
γ-Glutamate transpeptidase | 931 U/L | 10-60 U/L |
Total bile acid | 81.92 µmol/L | 0-10 µmol/L |
Serum albumin | 34.7 g/L | 40-55 g/L |
Total bilirubin | 113 µmol/L | 0-23 µmol/L |
Direct bilirubin | 93.4 µmol/L | 0-8 µmol/L |
Hepatitis A antibodies | Negative | Negative |
Hepatitis B markers | Negative | Negative |
Hepatitis C antibodies | Negative | Negative |
Hepatitis E antibodies | Negative | Negative |
Anti-neutrophil cytoplasmic antibodies | Negative | Negative |
Antinuclear antibodies | Negative | Negative |
Extractable nuclear antigen | Negative | Negative |
Ceruloplasmin | 33.4 mg/dL | 22-58 mg/dL |
Procalcitonin | 0.132 ng/mL | 0-0.05 ng/mL |
Urinary immunoglobulin κ-light chain | 0.148 g/L | 0-0.02 g/L |
Urinary immunoglobulin λ-light chain | 0.05 g/L | 0-0.05 g/L |
- Citation: Chen Y, Peng J, Wang Y, Xiao LH, Liu F, Wei YB, Wu XF, Wang LW. Hepatic amyloidosis in a patient with chronic liver failure: A case report. World J Clin Cases 2024; 12(19): 3918-3924
- URL: https://www.wjgnet.com/2307-8960/full/v12/i19/3918.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i19.3918